Zobrazeno 1 - 10
of 255
pro vyhledávání: '"Michael G, Stabin"'
Autor:
Francesco Cicone, David Viertl, Thibaut Denoël, Michael G. Stabin, John O. Prior, Silvano Gnesin
Publikováno v:
EJNMMI Research, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Background Extrapolation of human absorbed doses (ADs) from biodistribution experiments on laboratory animals is used to predict the efficacy and toxicity profiles of new radiopharmaceuticals. Comparative studies between available animal-to-
Externí odkaz:
https://doaj.org/article/f23525774a0d443a9463dd84c25029a6
Autor:
Michael G. Stabin
Publikováno v:
Health Physics. 124:397-406
Autor:
Thomas Lee Collier, Marc D. Normandin, Nickeisha A. Stephenson, Eli Livni, Steven H. Liang, Dustin W. Wooten, Shadi A. Esfahani, Michael G. Stabin, Umar Mahmood, Jianqing Chen, Wei Wang, Kevin Maresca, Rikki N. Waterhouse, Georges El Fakhri, Paul Richardson, Neil Vasdev
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-12 (2017)
Lorlatinib—a ROS1/ALK inhibitor—is currently undergoing clinical trials for the treatment of non-small cell lung cancers. Here the authors develop synthetic routes to11C- and 18F-labelled lorlatinib, with subsequent PET imaging showing good blood
Externí odkaz:
https://doaj.org/article/c6a81b2a14fd4e259767853846c7c586
Autor:
Ronald H. Lands, Michael G. Stabin, Dustin Powell, Bryan Whittle, Aaron Endsley, Alan Stuckey, Ryan R. Julian, Tyler R. Lambeth, Emily B. Martin, Stephen J. Kennel, Angela Williams, Jonathan S. Wall, Sarah Hall
Publikováno v:
Molecular Imaging and Biology. 24:479-488
Purpose Accurate diagnosis of amyloidosis remains a significant clinical challenge and unmet need for patients. The amyloid-reactive peptide p5+14 radiolabeled with iodine-124 has been developed for the detection of amyloid by PET/CT imaging. In a fi
Autor:
Michael G. Stabin
Publikováno v:
Journal of Nuclear Medicine. 61:30S-41S
The internal dosimetry of β- and γ-emitters has been established by several authors. Smith ([1][1]) cites the work of Loevinger et al. ([2][2]) and Ellet et al. ([3][3]), pioneers in the field. Somehow, internal dosimetry manages to intimidate many
Autor:
Michael G. Stabin
Publikováno v:
Handbook of Nuclear Medicine and Molecular Imaging for Physicists ISBN: 9780429489549
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1f54512e0cd2525560a8c577958e25d
https://doi.org/10.1201/9780429489549-9
https://doi.org/10.1201/9780429489549-9
Autor:
Michael G. Stabin
Publikováno v:
Handbook of Nuclear Medicine and Molecular Imaging for Physicists ISBN: 9780429489549
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba9eed68ee1885c99bb2dd0c8ccd8929
https://doi.org/10.1201/9780429489549-7
https://doi.org/10.1201/9780429489549-7
Autor:
Michael G, Stabin
Publikováno v:
Health Physics. 122:513-514
Autor:
Bernardo Maranhão Dantas, Ana Letícia Almeida Dantas, Fábio Luiz Navarro Marques, Luiz Bertelli, Michael G. Stabin
Publikováno v:
Brazilian Archives of Biology and Technology, Vol 48, Iss spe2, Pp 215-220 (2005)
99mTc is a radionuclide widely used for imaging diagnosis in nuclear medicine. In Brazil it is obtained by elution from 99Mo-99mTc generators supplied by the Nuclear Energy Research Institute (IPEN). The elution is carried out in radiopharmacy labora
Externí odkaz:
https://doaj.org/article/0da36f12a66142d2a91c331922f0eccc
Publikováno v:
Medical Physics, Vol. 46, No 11 (2019) pp. 4713-4716
This is an exciting time for targeted molecular radiotherapy. Recent advances in the field of theranostics are enabling the implementation of innovative approaches for the treatment of a plethora of systemic malignancies. Theranostics introduced a pa